134 related articles for article (PubMed ID: 25847930)
1. Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure.
Rozovski U; Benjamini O; Jain P; Thompson PA; Wierda WG; O'Brien S; Burger JA; Ferrajoli A; Faderl S; Shpall E; Hosing C; Khouri IF; Champlin R; Keating MJ; Estrov Z
J Clin Oncol; 2015 May; 33(14):1557-63. PubMed ID: 25847930
[TBL] [Abstract][Full Text] [Related]
2. Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.
Gribben JG; Zahrieh D; Stephans K; Bartlett-Pandite L; Alyea EP; Fisher DC; Freedman AS; Mauch P; Schlossman R; Sequist LV; Soiffer RJ; Marshall B; Neuberg D; Ritz J; Nadler LM
Blood; 2005 Dec; 106(13):4389-96. PubMed ID: 16131571
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis.
Poon ML; Fox PS; Samuels BI; O'Brien S; Jabbour E; Hsu Y; Gulbis A; Korbling M; Champlin R; Abruzzo LV; Bassett RL; Khouri IF
Leuk Lymphoma; 2015 Mar; 56(3):711-5. PubMed ID: 24913509
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Richter's Transformation with Novel Therapies.
Bajwa A; Habib A; Kittai AS
Curr Hematol Malig Rep; 2024 Apr; 19(2):45-55. PubMed ID: 38194201
[TBL] [Abstract][Full Text] [Related]
5. Role of allogeneic transplantation in patients with chronic lymphocytic leukemia in the era of novel therapies: a review.
Mewawalla P; Nathan S
Ther Adv Hematol; 2014 Oct; 5(5):139-52. PubMed ID: 25324955
[TBL] [Abstract][Full Text] [Related]
6. Treatment Patterns and Outcomes in U.S. Military Veterans Diagnosed With Chronic Lymphocytic Leukemia (CLL).
Ma H; O'Brien S; Gupta P
Clin Lymphoma Myeloma Leuk; 2024 Feb; 24(2):77-82. PubMed ID: 37743181
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
Hallek M
Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
[TBL] [Abstract][Full Text] [Related]
8. Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT.
Ryan CE; Sahaf B; Logan AC; O'Brien S; Byrd JC; Hillmen P; Brown JR; Dyer MJ; Mato AR; Keating MJ; Jaglowski S; Clow F; Rezvani AR; Styles L; Coutre SE; Miklos DB
Blood; 2016 Dec; 128(25):2899-2908. PubMed ID: 27802969
[TBL] [Abstract][Full Text] [Related]
9. Hope for high-risk chronic lymphocytic leukemia relapsing after allogeneic stem-cell transplantation.
Montserrat E; Dreger P
J Clin Oncol; 2015 May; 33(14):1527-9. PubMed ID: 25870086
[No Abstract] [Full Text] [Related]
10. Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?
Montserrat E; Dreger P
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S74-81. PubMed ID: 27521330
[TBL] [Abstract][Full Text] [Related]
11. High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.
Reljic T; Kumar A; Djulbegovic B; Kharfan-Dabaja MA
Bone Marrow Transplant; 2015 Aug; 50(8):1069-74. PubMed ID: 25867647
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma.
Zhang SQ; Smith SM; Zhang SY; Lynn Wang Y
Br J Haematol; 2015 Aug; 170(4):445-56. PubMed ID: 25858358
[TBL] [Abstract][Full Text] [Related]
13. Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.
Maddocks KJ; Ruppert AS; Lozanski G; Heerema NA; Zhao W; Abruzzo L; Lozanski A; Davis M; Gordon A; Smith LL; Mantel R; Jones JA; Flynn JM; Jaglowski SM; Andritsos LA; Awan F; Blum KA; Grever MR; Johnson AJ; Byrd JC; Woyach JA
JAMA Oncol; 2015 Apr; 1(1):80-7. PubMed ID: 26182309
[TBL] [Abstract][Full Text] [Related]
14. The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease.
Rhoades R; Gaballa S
Biomedicines; 2017 Oct; 5(4):. PubMed ID: 29039818
[TBL] [Abstract][Full Text] [Related]
15. Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant.
Master S; Leary C; Takalkar A; Coltelingam J; Mansour R; Mills GM; Koshy N
Case Rep Oncol; 2017; 10(2):534-541. PubMed ID: 28690529
[TBL] [Abstract][Full Text] [Related]
16. Three years of ibrutinib in CLL.
Forconi F
Blood; 2015 Apr; 125(16):2455-6. PubMed ID: 25883227
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Richter's Syndrome.
Condoluci A; Rossi D
Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.
Wang ML; Blum KA; Martin P; Goy A; Auer R; Kahl BS; Jurczak W; Advani RH; Romaguera JE; Williams ME; Barrientos JC; Chmielowska E; Radford J; Stilgenbauer S; Dreyling M; Jedrzejczak WW; Johnson P; Spurgeon SE; Zhang L; Baher L; Cheng M; Lee D; Beaupre DM; Rule S
Blood; 2015 Aug; 126(6):739-45. PubMed ID: 26059948
[TBL] [Abstract][Full Text] [Related]
19. The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.
Balakrishnan K; Peluso M; Fu M; Rosin NY; Burger JA; Wierda WG; Keating MJ; Faia K; O'Brien S; Kutok JL; Gandhi V
Leukemia; 2015 Sep; 29(9):1811-22. PubMed ID: 25917267
[TBL] [Abstract][Full Text] [Related]
20. Jumping translocations, a novel finding in chronic lymphocytic leukaemia.
Miller CR; Stephens D; Ruppert AS; Racke F; McFaddin A; Breidenbach H; Lin HJ; Waller K; Bannerman T; Jones JA; Woyach JA; Andritsos LA; Maddocks K; Zhao W; Lozanski G; Flynn JM; Grever M; Byrd JC; Heerema NA
Br J Haematol; 2015 Jul; 170(2):200-7. PubMed ID: 25891862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
